AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023
2023年5月30日 - 5:05AM
ビジネスワイヤ(英語)
AbCellera (Nasdaq: ABCL) today announced that executives from
the Company will present at the Goldman Sachs 44th Annual Global
Healthcare Conference in Dana Point, California on Tuesday, June
13, 2023, at 1:20 p.m. Pacific Time (4:20 p.m. Eastern Time).
A live audio webcast of the presentation may be accessed through
a link that will be posted on AbCellera's Investor Relations
website. A replay will be available through the same link following
the presentation.
About AbCellera Biologics Inc.
AbCellera is breaking the barriers of conventional antibody
discovery to bring better medicines to patients, sooner.
AbCellera’s engine integrates expert teams, technology, and
facilities with the data science and automation needed to propel
antibody-based medicines from target to clinic in nearly every
therapeutic area with precision and speed. AbCellera provides
innovative biotechs and leading pharmaceutical companies with a
competitive advantage that empowers them to move quickly, reduce
cost, and tackle the toughest problems in drug development. For
more information, please visit www.abcellera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230525005760/en/
Inquiries Media: Jessica Yingling, Ph.D.;
media@abcellera.com, +1(236)521-6774 Business Development: Murray
McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005 Investor
Relations: Josephine Hellschlienger, Ph.D.; ir@abcellera.com,
+1(778)729-9116
AbCellera Biologics (NASDAQ:ABCL)
過去 株価チャート
から 4 2024 まで 5 2024
AbCellera Biologics (NASDAQ:ABCL)
過去 株価チャート
から 5 2023 まで 5 2024